A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; Maleic acid; Timolol

Criteria

Inclusion Criteria:

• Diagnosed with open-angle glaucoma (with ot without pseudoexfoliation or pigment dispersion component) or ocular hypertension

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Under 18

• Other protocol-defined exclusion criteria may apply.